References

  1. Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol. 1995;31B(2):86-99. PubMed | Google Scholar

  2. Arotiba JT, Ogunbiyi JO, Obiechina AE. Odontogenic tumours: a 15-year review from Ibadan, Nigeria. Br J Oral Maxillofac Surg. 1997;35(5):363-7. PubMed | Google Scholar

  3. Chidzonga MM, Lopez VM, Alverez AP. Odontogenic tumours; analysis of 148 cases in Zimbabwe. Cent Afr J Med. 1996;42(2):158-61. PubMed | Google Scholar

  4. Ladeinde AL, Ajayi OF, Ogunlewe MO, Adeyemo WL, Arotiba GT, Bamgbose BO, Akinwande JA. Odontogenic tumors: a retrospective analysis of 319 cases in a Nigerian teaching hospital. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(2):191-5. PubMed | Google Scholar

  5. Heikinheimo K, Jee KJ, Niini T, Aalto Y, Happonen RP, Leivo I, Knuutila S. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res. 2002;81(8):525-30. PubMed | Google Scholar

  6. Kumamoto H, Ooya K. Immunohistochemical detection of BH3-only proteins in ameloblastic tumors. Oral Dis. 2008;14(6):550-5. PubMed | Google Scholar

  7. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM, Beachy PA. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 2002;297(5586):1559-1561. PubMed | Google Scholar

  8. Yanai K, Nagai S, Wada J, Yamanaka N, Nakamura M, Torata N, Noshiro H, Tsuneyoshi M, Tanaka M, Katano M. Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J Surg Oncol. 2007;95(1):55-62. PubMed | Google Scholar

  9. Koyama E, Wu C, Shimo T, Iwamoto M, Ohmori T, Kurisu K, Ookura T, Bashir MM, Abrams WR, Tucker T, Pacifici M. Development of stratum intermedium and its role as a Sonic hedgehog signalling structure during odontogenesis. Dev Dyn. 2001;222(2):178-191. PubMed | Google Scholar

  10. DeVilliers P, Suggs C, Simmons D, Murrah V, Wright JT. Microgenomics of Ameloblastoma. J Dent Res. 2011;90(4):463-469. PubMed | Google Scholar

  11. Nishimaki H, Kasai K, Kozaki K, Takeo T, Ikeda H, Saga S, Nitta M, Itoh G. A role of activated Sonic hedgehog signalling for the cellular proliferation of oral squamous cell carcinoma cell line. Biochem Biophys Res Commun. 2004;314(2):313-320. PubMed | Google Scholar

  12. Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Johnson MR, Frost AR. Hedgehog signalling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther. 2006;5(6):674-683. PubMed | Google Scholar

  13. Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein. Cell Mol Life Sci. 1999;55:96-107. PubMed | Google Scholar

  14. Asslaber D, Pinon JD, Seyfried J, Desch P, Stocher M, Tinhofer I, Egle A, Merkel O, Grell R. microRNA-34a expression correlates with MDM2 SNP 309 polymorphism and treatment free survival in chronic lymphocytic leukemia. Blood. 2010;115:4191-7. PubMed | Google Scholar

  15. Krishna A, Kaveri H, Naveen Kumar R K, Kumaraswamy K L, Shylaja S, Murthy S. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor. J Can Res Ther. 2012;8(2):232-7. PubMed | Google Scholar

  16. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 onco-protein expression during colorectal tumorigenesis. Cancer Res. 1995;55:237-41. PubMed | Google Scholar

  17. Shiori K, Takeshi M, Yu N, Shintaro K, Yuichi G, Ryota M, Seiji N. Anti-apoptotic role of the sonic hedgehog signaling pathway in the proliferation of ameloblastoma. International Journal of Oncology. 2013;43(3):695-702. PubMed | Google Scholar

  18. Ren C, Amm HM, DeVilliers P, Wu Y, Deatherage JR, Liu Z, MacDougall M. Targeting the sonic hedgehog pathway in keratocystic odontogenic tumor. J Biol Chem. 2012;287(32):27117-25. PubMed | Google Scholar

  19. Vered M, Peleg O, Taicher S, Buchner A. The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts. J Oral Pathol Med. 2009;38(7):597-604. PubMed | Google Scholar

  20. Rosenstein T, Pogrel MA, Smith RA, Regezi JA. Cystic ameloblastoma behavior and treatment of 21 cases: ; discussion 1316-8. J Oral Maxillofac Surg. 2001 Nov;59(11):1311-6. PubMed | Google Scholar

  21. Al-Salihi KA, Li LY, Azlina A. P53 gene mutation and protein expression in ameloblastomas. Braz J Oral Sci. 2006;5(17):1034-1040. PubMed | Google Scholar

&